99 related articles for article (PubMed ID: 6236861)
21. Urinary glycosaminoglycan (uGAG) excretion in healthy pediatric and adolescent population.
Komosinska-Vassev K; Blat D; Olczyk P; Szeremeta A; Jura-Półtorak A; Winsz-Szczotka K; Klimek K; Olczyk K
Clin Biochem; 2014 Sep; 47(13-14):1341-3. PubMed ID: 24956269
[TBL] [Abstract][Full Text] [Related]
22. Urinary acid glycosaminoglycans in a patient with oculo-cerebro-renal syndrome.
Hayashi S; Nagata T; Kimura A; Tsurumi K
Tohoku J Exp Med; 1978 Nov; 126(3):225-34. PubMed ID: 734647
[TBL] [Abstract][Full Text] [Related]
23. Urinary excretion of acid glycosaminoglycans and its relationship to proteinuria.
Kircher S; Lubec G
Nephron; 1986; 42(3):275-6. PubMed ID: 3080691
[No Abstract] [Full Text] [Related]
24. Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.
Hinek A; Wilson SE
Am J Pathol; 2000 Mar; 156(3):925-38. PubMed ID: 10702409
[TBL] [Abstract][Full Text] [Related]
25. Dermatan sulfate and heparan sulfate as a biomarker for mucopolysaccharidosis I.
Tomatsu S; Montaño AM; Oguma T; Dung VC; Oikawa H; de Carvalho TG; Gutiérrez ML; Yamaguchi S; Suzuki Y; Fukushi M; Sakura N; Barrera L; Kida K; Kubota M; Orii T
J Inherit Metab Dis; 2010 Apr; 33(2):141-50. PubMed ID: 20162367
[TBL] [Abstract][Full Text] [Related]
26. Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease.
Church H; Tylee K; Cooper A; Thornley M; Mercer J; Wraith E; Carr T; O'Meara A; Wynn RF
Bone Marrow Transplant; 2007 Feb; 39(4):207-10. PubMed ID: 17220904
[TBL] [Abstract][Full Text] [Related]
27. [Some metabolic values of acid mucopolysaccharides in myopia (author's transl)].
Avetisow ES; Winezkaja MI; Sawizkaja NF
Klin Monbl Augenheilkd; 1976 Jun; 168(6):750-4. PubMed ID: 136545
[TBL] [Abstract][Full Text] [Related]
28. Urinary acid mucopolysaccharides in multiple sulfatase deficiency (mucosulfatidosis).
Eto Y; Numaguchi S; Handa T
Eur J Pediatr; 1979 Nov; 132(3):207-11. PubMed ID: 159821
[TBL] [Abstract][Full Text] [Related]
29. Clinical and biochemical changes in a child with type I mucopolysaccharidosis during long-term transfusion of leukocytes.
Toma L; Pinto W; Nader HB; Dietrich CP
Braz J Med Biol Res; 1983 Apr; 16(1):29-33. PubMed ID: 6227354
[TBL] [Abstract][Full Text] [Related]
30. The effect of retinol (vitamin-A alcohol) on urinary excretion of mucopolysaccharides in the Hurler syndrome.
Danes BS; Bearn AG
Lancet; 1967 May; 1(7498):1029-30. PubMed ID: 4164466
[No Abstract] [Full Text] [Related]
31. Noninvasive diagnosis of tubular damage by the use of the urinary chondroitin-4-sulfate/heparan sulfate ratio.
Lubec G; Kircher S; Grillenberger A
Padiatr Padol; 1986; 21(4):357-61. PubMed ID: 2951642
[TBL] [Abstract][Full Text] [Related]
32. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
[TBL] [Abstract][Full Text] [Related]
33. Keratan and herparan sulfaturia: glucosamine-6-sulfate deficiency.
Matalon R; Wappner R; Deanching M; Brandt IK; Horwitz A
Ann Clin Lab Sci; 1982; 12(3):234-8. PubMed ID: 6212020
[TBL] [Abstract][Full Text] [Related]
34. Composition of urinary glycosaminoglycans in a patient with juvenile hyaline fibromatosis.
Leta G; Abad ED; Martins RC; Dellias JM; Silva LC
Clin Chim Acta; 2004 Mar; 341(1-2):205-7. PubMed ID: 14967178
[No Abstract] [Full Text] [Related]
35. Degree of sulfation in mucopolysaccharide sulfates in normal and stone-forming urines.
Foye WO; Hong HS; Kim CM; Prien EL
Invest Urol; 1976 Jul; 14(1):33-7. PubMed ID: 134003
[TBL] [Abstract][Full Text] [Related]
36. Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes.
Ramage P; Cunningham WL
Biochim Biophys Acta; 1975 Dec; 411(2):325-33. PubMed ID: 127616
[TBL] [Abstract][Full Text] [Related]
37. White matter changes mimicking a leukodystrophy in a patient with Mucopolysaccharidosis: characterization by MRI.
Barone R; Parano E; Trifiletti RR; Fiumara A; Pavone P
J Neurol Sci; 2002 Mar; 195(2):171-5. PubMed ID: 11897250
[TBL] [Abstract][Full Text] [Related]
38. Biomarker responses correlate with antibody status in mucopolysaccharidosis type I patients on long-term enzyme replacement therapy.
Langereis EJ; van Vlies N; Church HJ; Geskus RB; Hollak CE; Jones SA; Kulik W; van Lenthe H; Mercer J; Schreider L; Tylee KL; Wagemans T; Wijburg FA; Bigger BW
Mol Genet Metab; 2015 Feb; 114(2):129-37. PubMed ID: 25467058
[TBL] [Abstract][Full Text] [Related]
39. Quantitative measurement of sulphated glycosaminoglycans in urine.
Sloan R; Elliott RJ
Biochem Soc Trans; 1996 Feb; 24(1):102S. PubMed ID: 8674581
[No Abstract] [Full Text] [Related]
40. Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase).
Wraith JE; Beck M; Lane R; van der Ploeg A; Shapiro E; Xue Y; Kakkis ED; Guffon N
Pediatrics; 2007 Jul; 120(1):e37-46. PubMed ID: 17606547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
